Kestra Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Kestra Advisory Services’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$114K	Sell
2025 Q1	$95.4K	Sell
2024 Q4	$96.4K	Buy
2023 Q4	–	Sell
2023 Q3	$133K	Sell
2023 Q2	$184K	Buy
2023 Q1	$200K	Buy
2022 Q4	$247K	Buy
2022 Q3	$180K	Buy